![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Assura Plc | LSE:AGR | London | Ordinary Share | GB00BVGBWW93 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.38 | -0.90% | 41.74 | 41.60 | 41.66 | 42.00 | 41.50 | 42.00 | 2,604,188 | 16:35:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Real Estate Agents & Mgrs | 157.8M | -28.8M | -0.0097 | -42.91 | 1.25B |
TIDMAGR
RNS Number : 1029F
Assura PLC
06 July 2023
6 July 2023
Assura plc
Trading Update
For the first quarter ending 30 June 2023
Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2023.
Jonathan Murphy, CEO, said:
"Assura has delivered another quarter of strong financial performance and disciplined activity.
"Our on-site activities progressed well, with two developments and one asset enhancement project reaching practical completion, providing high quality premises and enabling an improved range of health services for patients.
"We made good progress with rent reviews over the period, settling a further 55 reviews to generate an uplift of GBP0.6 million.
"We continue to see many opportunities to work with the NHS in providing critical primary care infrastructure. Our leading market position, strong and sustainable financial position and pipeline of growth opportunities will allow us to continue to deliver against our proven strategy."
Continued strong track record of disciplined activity through first quarter
-- Portfolio of 610 properties with an annualised rent roll of GBP145.3 million
-- Two developments completed; our 100(th) development in Wolverhampton (as announced 29 June 2023) and our GBP22 million scheme in Kettering
-- Completed one asset enhancement capital project (total spend GBP1.1 million); on site with a further nine (total spend GBP8.2 million)
-- 55 rent reviews settled in the quarter, covering GBP5.5 million of existing rent and generating an uplift of GBP0.6 million
-- Quarterly dividend increased by 5% to 0.82 pence per share, as announced at the full year results, with effect from the July 2023 payment
Development and asset enhancement pipelines provide growth opportunities
-- Currently on site with nine developments; total cost of GBP103 million (March 2023: 11, GBP129 million) of which GBP45 million has been spent to date
-- Immediate development pipeline of five schemes, where we would normally expect to be on site within 12 months; total cost of GBP35 million (March 2023: 5, GBP37 million). We continue to experience delays on pipeline schemes as we negotiate to ensure rents appropriately reflect the current cost of construction.
-- 36 lease re-gears covering GBP8.4 million of existing rent roll in the current pipeline
-- Pipeline of 17 capital asset enhancement projects (projected spend GBP11 million) over the next two years
Strong and sustainable financial position
-- Weighted average interest rate unchanged at 2.30% (March 2023: 2.30%); all drawn debt on fixed rate basis
-- Weighted average debt maturity of 6.8 years, no refinancing on drawn debt due until October 2025. Over 50% of drawn debt matures beyond 2030, with our longest maturity debt at our lowest rates
-- Net debt of GBP1,144 million on a fully unsecured basis with cash and undrawn facilities of GBP234 million
- ENDS -
Assura plc Tel: 01925 945354 Jayne Cottam, CFO E mail: Investor@assura.co.uk David Purcell, Investor Relations Director FGS Global Tel: 0207 251 3801 Gordon Simpson Email: Assura@fgsglobal.com James Thompson
Notes to Editors
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at GBP2.7 billion.
At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.
Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
Assura plc LEI code: 21380026T19N2Y52XF72
*EPRA is a registered trademark of the European Public Real Estate Association.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTFLFIRDTIEIIV
(END) Dow Jones Newswires
July 06, 2023 02:00 ET (06:00 GMT)
1 Year Assura Chart |
1 Month Assura Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions